Mohawk Medbuy Corporation’s Post

In a recent Pharmaceutical Commerce article, #SyneosHealth industry expert Dave MacLeod, Managing Director of Consulting, discusses the most important attributes when choosing a specialty pharmacy partner. Dive in: https://lnkd.in/euMpbcmR #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers 

The #pharma landscape is constantly evolving, and a Specialty Pharmacy Network strategy developed even a year ago might not be optimal for the future. As we quickly approach 2025, it's a critical time for pharmaceutical manufacturers to revisit their annual pharmacy strategy. Contact Archbow today to ensure your 2025 plan is on track to deliver the support your patients need. Read our blog to learn more. #biotech #specialtypharmacy 

The Senate unanimously passed the Affordable Prescriptions for Patients Act on July 11. Brought forth by Senators John Cornyn (R-TX) and Richard Blumenthal (D-CT), this bipartisan bill aims to reduce prescription drug costs by addressing "patent thickets" created by pharmaceutical companies. By promoting competition and enabling biosimilars to enter the market, the legislation seeks to make medications more affordable for consumers, prioritizing health over profits. #Healthcare #Pharma #Legislation #AffordableDrugs Click the link below for further information! https://lnkd.in/ejDKKE-E

Despite the challenges the wholesale pharmaceutical community faces, we are well-prepared for the upcoming DSCSA deadline on November 27th. VP of Manufacturer Operations and Data Services Gregg Gorniak detailed our proactive approach for enhancing our relationship with manufacturers and addressing drug shortages in a recent Pharmaceutical Commerce Magazine article: https://ow.ly/t8G650TeFyI #DSCSADeadline #pharmasupplychain

In this Pharmaceutical Commerce article, our industry expert Dave MacLeod, Managing Director of Consulting, discusses the most important attributes when choosing a specialty pharmacy partner. Dive in: https://ow.ly/32cQ30sHlrR #SyneosHealth

In a recent Pharmaceutical Commerce article, #SyneosHealth industry expert Dave MacLeod, Managing Director of Consulting, discusses the most important attributes when choosing a specialty pharmacy partner. Dive in: https://lnkd.in/dV_q4SgH #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers 

In this Pharmaceutical Commerce article, our industry expert Dave MacLeod, Managing Director of Consulting, discusses the most important attributes when choosing a specialty pharmacy partner. Dive in: https://ow.ly/69C130sHfWt #SyneosHealth

On November 17, 2023, CMS released final program guidance to pharmaceutical manufacturers and Part D plan sponsors for implementing the Medicare Part D Manufacturer Discount Program for 2025 and 2026. This paper summarizes the key provisions of the MDP final guidance and other subsequent guidance, including a summary of programmatic differences and similarities to the previous Coverage Gap Discount Program (CGDP), an analysis of the impact of a phase-in of manufacturer discounts, and its potential implications to various stakeholders. Featured Authors: Jimmy Mans, David Walters, Sarah Legatt, #Wakely #Medicare #PartD #IRA #ManufacturerDiscountProgram

In a recent Pharmaceutical Commerce article, #SyneosHealth industry expert Dave MacLeod, Managing Director of Consulting, discusses the most important attributes when choosing a specialty pharmacy partner. Dive in: https://lnkd.in/ePWpyy-C #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers 

In this Pharmaceutical Commerce Magazine article, our industry expert Dave MacLeod, Managing Director of Consulting, discusses the most important attributes when choosing a specialty pharmacy partner. Dive in: https://lnkd.in/gibzXZ5P #SyneosHealth